The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Artesunate Amivas Amivas Australia Pty Ltd
Product name
Artesunate Amivas
Sponsor
Accepted date
Aug-2024
Active ingredients
Artesunate
Proposed indication
Initial treatment of severe malaria in adults and children
Application type
A (new medicine)
Publication date
Aug-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.
Priority review
Involves faster TGA evaluation of vital and life-saving medicines for which a complete data dossier is available.